Finerenone Patent Expiration
Finerenone was first introduced by Bayer Healthcare Pharmaceuticals Inc
Finerenone Patents
Given below is the list of patents protecting Finerenone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kerendia | USRE49826 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient | Jul 29, 2035 | Bayer Hlthcare |
| Kerendia | US8436180 | Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | Apr 12, 2029 | Bayer Hlthcare |
Finerenone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List